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ABSTRACT
Objectives: To explore the experiences of patients
and professionals taking part in a randomised
controlled trial (RCT) of blood glucose, blood pressure
(BP) and weight telemonitoring in type 2 diabetes
supported by primary care, and identify factors
facilitating or hindering the effectiveness of the
intervention and those likely to influence its potential
translation to routine practice.
Design: Qualitative study adopting an interpretive
descriptive approach.
Participants: 23 patients, 6 nurses and 4 doctors
who were participating in a RCT of blood glucose and
BP telemonitoring. A maximum variation sample of
patients from within the trial based on age, sex and
deprivation status of the practice was sought.
Setting: 12 primary care practices in Scotland and
England.
Method: Data were collected via recorded
semistructured interviews. Analysis was inductive with
themes presented within an overarching thematic
framework. Multiple strategies were employed to
ensure that the analysis was credible and trustworthy.
Results: Telemonitoring of blood glucose, BP and
weight by people with type 2 diabetes was feasible.
The data generated by telemonitoring supported self-
care decisions and medical treatment decisions.
Motivation to self-manage diet was increased by
telemonitoring of blood glucose, and the ‘benign
policing’ aspect of telemonitoring was considered by
patients to be important. The convenience of home
monitoring was very acceptable to patients although
professionals had some concerns about telemonitoring
increasing workload and costs.
Conclusions: Telemonitoring of blood glucose, BP
and weight in primary care is a promising way of
improving diabetes management which would be
highly acceptable to the type of patients who
volunteered for this study.
Trial registration number: ISRCTN71674628;
Pre-results.
BACKGROUND
As the population ages, more people live
with long-term conditions, particularly type 2
diabetes. The WHO estimates that globally
8–10% of adults over the age of 25 have dia-
betes, approximately 90% with type 2 dia-
betes.1 Close control of blood glucose and
blood pressure (BP) can reduce morbidity.2–4
As the prevalence of chronic conditions such
as type 2 diabetes increases, it will become dif-
ﬁcult to continue to provide the same level of
healthcare stafﬁng to manage these condi-
tions as we do now. Many healthcare strategy
documents advocate the use of telehealth
(particularly telemonitoring and teleconsul-
tation)5 to streamline and improve the man-
agement of long-term conditions and
produce engaged6 and activated7 patients
who manage their own condition well, requir-
ing fewer consultations and fewer admissions
to hospital. However, despite numerous pilot
studies, the uptake of telehealth has been
limited and in the UK and some healthcare
providers are now disinvesting in telemonitor-
ing technologies for a range of reasons8
including negative results from some trials,
and the cost and difﬁculty in sourcing systems
which meet their needs.9 10 Telemonitoring,
where the patient regularly measures signs
and symptoms at home and makes them elec-
tronically available to their healthcare pro-
vider, is a complex intervention, requiring
input from patients and providers. Analysis of
the reasons for effectiveness or otherwise of
complex interventions is best addressed using
qualitative methods.11 This paper presents
Strengths and limitations of this study
▪ Trial context led to wide range of practices
participating.
▪ Telemonitoring was provided within the practice
by the .patients’ usual clinicians.
▪ Small numbers telemonitoring in each practice.
▪ The practices involved had low non-Caucasian
ethnic minority populations who are at higher
risk of type 2 diabetes.
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the results of a qualitative study of telemonitoring in type
2 diabetes in the context of the effective Telescot
Diabetes randomised controlled trial (RCT) which will
be reported elsewhere (Trial registration number
ISRCTN71674628).12
Good blood glucose control and good BP control
(<130/80 mm Hg) can substantially reduce the risk of
cardiovascular complications in people with type 2 dia-
betes.13 However, evidence of the value of self-
monitoring blood glucose for those who are not on
insulin is mixed.14 It is not routinely recommended in
the UK,13 14 due to cost concerns and research suggest-
ing that it does not improve control and may increase
anxiety.15 Syntheses of qualitative studies16 17 report that
self blood glucose monitoring has a perceived negative
impact on quality of life where the monitoring identiﬁes
problems which are not addressed, for example, when
patients were aware of high readings for long periods in
between clinic appointments.18 In contrast, telemonitor-
ing provides timely sharing of clinical information with
healthcare providers and the limited evidence available
suggests it helps improve blood glucose control in type 2
diabetes,19 although the authors of a recent analysis of
data from a large cluster RCT in England suggest that
the improvement in blood glucose control may not be
large enough to be clinically signiﬁcant.20 The evidence
for telemonitoring BP is growing,21–26 but the acceptabil-
ity and impact of this in people with type 2 diabetes who
are also being asked to monitor their blood glucose is
unclear.
The Telescot programme consisted of a series of ran-
domised controlled trials with embedded qualitative
studies in telemonitoring in chronic obstructive pulmon-
ary disease (COPD), hypertension and diabetes, with
additional pilot and qualitative studies of telemonitoring
in heart failure and hypertension following stroke. The
deﬁning feature of this programme was that, unlike in
many previous pilots/trials, telemonitoring was provided
by the patients’ usual primary care practitioners so that
apart from the telemonitoring, the same care was avail-
able to control and intervention groups. This approach
was shown to be effective in improving the management
of BP in people who did not have diabetes. In the trial
which was the context for this qualitative study people
with type 2 diabetes were asked to telemonitor three risk
factors, blood glucose, BP and weight over a period of
9 months. This added complexity to telemonitoring for
patients and practitioners, necessitating this qualitative
study to examine process and reasons for the effective-
ness or otherwise of this complex intervention. All
patients had poor blood glucose control at the start of
the study, but not necessarily poor BP control.12
A number of qualitative studies from this programme
have already been published27–33 and strong themes are
emerging. Broadly, the previous studies indicated that
telemonitoring is welcomed by patients who ﬁnd it con-
venient,27 31 appreciate being ‘watched over’28 29 and
ﬁnd the data reassuring.27 29 32 Some found it
empowered them to use the healthcare system more efﬁ-
ciently and effectively.27 29 However, although healthcare
practitioners recognised the potential patient beneﬁts,
they were concerned that some patients may become
dependent on the technology and anxious about their
condition,27–30 32 that responding to telemonitoring
data did not ﬁt with their customary ways of working27 33
and that it increased consultation rates.27 29 There was a
difference in response to the parameters being moni-
tored, with home BP measures providing a trusted basis
for treatment modiﬁcation and thus an improvement on
surgery measurement27 compared with COPD, where
the parameters measured (symptom scores, pulse oxim-
etry and forced expiratory volume in 1 s) did not
provide a reliable basis for treatment decisions without
further investigation.28 29 32
METHODS
Overview
This study was embedded within a multicentre RCT of
blood glucose, BP and weight telemonitoring in routine
care for patients whose glycated haemoglobin (HbA1c)
was above the target range (box 1).12 Qualitative data
were collected via semistructured interviews with partici-
pating patients and professionals. An interpretive descrip-
tive approach34 was employed, acknowledging that in
health services research the need of the researcher is not
simply to provide a description of the phenomenon, but
also to produce an interpretive account which will help to
guide healthcare innovation while, at the same time,
recognising the subjective nature of the encounter
between the participant and the researcher.35 Although
there is evidence from our own and others’ research, that
patients’ and professionals’ perceptions and experiences
of telemonitoring may differ27–32 36 37 both perspectives
need to be considered together in the context of an inter-
pretive descriptive approach to a service delivered in
partnership, and are necessary to inform a rounded inter-
pretation of the data in this study.38
Box 1 Telemonitoring intervention
Participants in the telemonitoring group were given instructions
for use of blood pressure (BP), blood glucose and weight moni-
tors which used Bluetooth technology to transmit readings via a
supplied modem to a remote secure server. The participant and
their primary care professionals were able to access password-
protected records on the server. Participants were asked to
measure one fasting and one non-fasting blood glucose at least
twice weekly and measure BP and weight at least weekly (with
increased testing as recommended by the clinician for people
treated with insulin). They were given advice on lifestyle modifica-
tion, on lag time for effects of lifestyle and medication change on
glucose and BP, and when and how to contact their healthcare
advisor. Primary care nurses were asked to check participants’
results weekly and to organise treatment changes based on
national guidelines for diabetes and hypertension management.
For full details please see the published protocol.12
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Ethics and governance considerations
The trial12 took place in general practitioner (GP) prac-
tices in three Health Board areas in Scotland (Lothian,
Borders, Greater Glasgow and Clyde) and one county in
England (Kent). The study received ethical approval
from the South East Scotland Ethics Service (10/S1102/
60) and R&D approvals from the Scottish Health Boards
and the Research Management and Governance
(RM&G) Consortium for Kent and Medway. This quali-
tative study took place in Lothian and Kent. Patients
were made aware that they may be approached for the
embedded qualitative study when they agreed to partici-
pate in the trial, but that participation in the qualitative
study would be optional. Patients and professionals
approached were sent a separate information sheet
about the qualitative study and gave additional written
consent prior to participation.
Sampling and recruitment
Forty-two GP practices and 321 patients participated in
the RCT. A maximum variation patient sample of at least
20 patients from the intervention arm from 12 of these
practices in Lothian and Kent (where the majority of
participating practices were located) was sought based
on age, sex and the deprivation status of the practice.
Patients participating in the trial were purposively
sampled and checks were made with the practice to
ensure that it was still appropriate to approach the
patient before they were contacted by letter. Those who
did not respond were replaced by patients taking part in
the trial with similar characteristics. The aim of this sam-
pling strategy was to capture a broad range of partici-
pant experiences across the socioeconomic spectrum.
Interviews were also sought with at least one professional
from each practice.
Data generation
Qualitative data were gathered through semistructured
interviews with patients, nurses and doctors. Initial topic
guides were based on issues identiﬁed in previous tele-
monitoring studies and were reﬁned iteratively in
response to the initial interviews. The ﬁnal topic guides
are shown in online supplementary appendix 1. Some
participants from Lothian were interviewed face-to-face
in their own home, and professionals at their workplace,
with all other interviews carried out by telephone.
Interviews were carried out by PF, a male qualitative
researcher who was not involved in the RCT.
Data handling and analysis
Data were collected between July 2011 and March 2012
and, with a little variation due to availability, in tranches
reﬂecting different start dates of the trial in different
practices. Provisional coding and identiﬁcation of
themes took place after each tranche of interviews.
Interviewing continued until the researcher, in discus-
sion with the wider research team, considered that data
saturation had been achieved. Although there is
discussion on the concept of data saturation,39 in the
context of this study it was considered to have occurred
when the researcher was not identifying any new themes
or codes within the provisional themes in sequential
interviews and thought this would be unlikely in subse-
quent interviews.
All interviews were recorded, fully transcribed and the
transcript checked against the recording. They were ana-
lysed thematically with initial codes and themes identi-
ﬁed inductively from the data. Patient and professional
data were initially coded separately and coding was
recorded using Nvivo V.7. Initial codes from patients and
professionals were grouped into themes and a frame-
work of overarching themes developed, in line with the
interpretive descriptive approach, with reference to the
purpose of this study. A range of strategies was employed
to ensure that the analysis was credible and trustworthy.
Constant comparison was used to ensure consistency in
coding and negative cases were sought for each coding
category. Coding was checked and iteratively reﬁned
using paired analysis of transcripts by two researchers
(PF and JH). Researcher reﬂexivity was supported by dis-
cussing emerging ﬁndings at regular meetings with the
wider research group where different explanations were
explored and the coding and thematic analysis reviewed
and reﬁned. In July 2012, the thematic analysis was pre-
sented by PF to a discussion group of researchers who
had participated in the Telescot programme. The pres-
entation introduced the themes and illustrative quotes
and the whole data set (all the text associated with each
code) was made available to the participants.
RESULTS
Thirty-six patient participants were approached and 23
interviewed, 16 men and 7 women, mean age 60 years.
Seven were interviewed face-to-face, the remainder by
telephone. Fourteen professionals were approached and
10 interviewed, 4 GPs and 6 practice nurses. Eight were
interviewed by telephone, two face-to-face.
Overview
The results are presented in the context of a broad over-
arching framework of factors which inﬂuence outcomes
and potential adoption of telemonitoring of type 2 dia-
betes in primary care including contextual factors, com-
munication (including performance of the technology),
telemonitoring as support for managing the condition,
and ‘ﬁt’ of telemonitoring with personal lifestyles and
professional practice in primary care. The coding frame
used in this study is available in online supplementary
appendix 2. In the illustrative quotes presented below,
practitioners are identiﬁed only by profession to reduce
the possibility of recognition.
Contextual factors
Patients and professionals spoke about a number of
aspects of the context into which telemonitoring was
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introduced which were likely to inﬂuence its impact. They
included patients’ prior experience of living with type 2
diabetes, the nature of usual care, preferred methods of
managing diabetes and the context of the clinical trial.
Living with type 2 diabetes
No patients in this study had newly diagnosed type 2 dia-
betes so all had experience of living with the condition.
Several patients described the expectation that they con-
stantly needed to self-manage their diabetes and the
wearisome nature of this.
I’ve been diabetic for quite a few years now and it’s quite
wearing and I go through phases where you just lose
interest, you know, and I’m told that’s quite normal.
(Patient 6, Male, 50–54 years, Kent)
Patients said less about their BP and appeared to be
less well informed about it
Interviewer: …when you’ve had your blood pressure
taken at the surgery, do they tell you the number?
Patient: Yes.
Interviewer: And is that actually helpful to know?
Patient: No. Because I’ve no idea what it should be… so
I’ve been on the net, checking what it should be.
(Patient 12, female, 60–64 years, Lothian.
Usual care
The frequency with which patients with type 2 diabetes
were seen in primary care prior to this trial varied.
Nurses pointed out that to some extent this was depend-
ent on the patients’ level of control (although all
patients in the trial had poor levels of diabetic control
recorded prior to recruitment) and different treatment
methods, with insulin treated patients requiring greater
supervision. However, there also appeared to be vari-
ation between practitioners
… every year with this new nurse …, but the one before
her used to take me in every four months and check me
out.
(Patient 1, male, 60–64 years, Lothian)
At the start of the trial three patients were already
monitoring their blood glucose and sharing the results
manually with their doctors or nurses at their regular
appointments. However, at least one of the nurses felt
that the value of this was limited for those patients who
did not share ‘bad’ readings.
if patients seem to have got really bad results, they tend
to forget their book! Or they’re not recording it anyway
(Practice nurse 10).
Preferred management options
Minimising medical intervention and managing diabetes
using lifestyle measures was clearly the ﬁrst choice of
approach.
She wants to put me on this glycoside tablet to enhance
whatever I’ve got in my body. I’m ﬁghting against it. I
says, I’ll try and get my weight down. When my weight
goes down, everything goes down, blood sugars and the
blood pressure goes down
(Patient 13, male, 60–64 years, Lothian)
The diabetic nurse has picked up the phone twice to call
me, looking at the results and to discuss a couple of
things, so that was quite useful… It’s actually led to a
radical change in diet, following a discussion she had
with our specialist diabetic GP
(Patient 6, male, 50–54 years, Kent)
However, for BP control, changes to medication initiated
by professionals were mentioned more frequently.
Yes, my diabetic practitioner nurse does call me about
the readings, in fact she has modiﬁed my blood pressure
control medication a couple of times to bring the levels
down to a more acceptable level, so yeah, it’s been a def-
inite beneﬁt I think
(Patient 7, male, 55–59 years, Kent).
Trialling
The ﬁnal major contextual factor was the trial itself. Both
patients and professionals appreciated being able to try
the systems without committing to using them on a long-
term basis, as well as the opportunity to contribute to
healthcare research. Thus, although all of the participants
were volunteers, the sample may have included people
who would not have agreed to use the system had it been
a long-term or (for professionals) full scale commitment.
Communication
The telemonitoring system was a vital aspect of commu-
nication and most people reported minor technical pro-
blems with the system at some point (mainly stemming
from one particular ﬁrmware update), but many people
were happy to continue to use it as part of a trial to help
determine the possibilities of telemonitoring. However
system failures were enough to put some patients off
continuing with telemonitoring.
but the second patient dropped out of the trial because
he moved house, but also he was having quite a lot of
problems with the equipment. I think [IT support] had
phoned me a couple of times because the Bluetooth
wasn’t working and I think he did get a bit disheartened
with it
(Practice nurse 9)
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Although patients could see their record on the inter-
net and there was a level of automated feedback from
the system, the system itself did not provide a simple way
of communicating asynchronously between patients and
professionals. In particular, patients were unable to tell
whether their readings had been viewed.
I think it’s quite good to put the information through. As
I say, Dr. [name] has only been in touch once, so
whether he’s actually looking at the thing I don’t know,
who can tell
(Patient 10, female, 70–74 years, Lothian)
So I don’t know whether the doctor must be looking at it,
or the nurse is maybe looking at it and no switched it off
(Patient 4, female, 50–54 years, Lothian)
There was uncertainty about who should be respon-
sible for initiating communication if readings were
outside the target range. Some patients would wait for
the practice nurse to contact them, which many did,
others would initiate the communication themselves.
But I don’t know what to do if…I think that if it goes
above 15, you have to do it again or something like
that… I would let my practice get in touch with me,
because I’m not very sure of what it all means.
(Patient 20, male, 55–59 years Lothian)
Well, I like to keep a weather eye on things. As for
instance, I noticed that my blood pressure was not very
high, but was in the high zone, and I brought that to
their attention and said I was concerned, you know, that
it should be lower. And as a consequence, they changed
the medication, and it is now within the realms of being
nearly normal now
(Patient 8, female, 50–54 years, Kent).
Telemonitoring as support for managing the condition
Telemonitoring data supported the management of
the condition in two ways—supporting self-care by
the patient and supporting treatment changes by the
primary care team/GP.
Supporting self-care
The use of the telemonitoring data to support self-care
was a strong theme. The response to high blood sugar
readings was immediate for some people.
but as far as I’m concerned the minute I see my blood
sugar high, I deﬁnitely don’t eat anything. I make sure to
try and bring it down.
(Patient 22, Male 50–54 years, Lothian)
it’s a good way of keeping track, on how you’re progres-
sing, and rather than going to the health centre every
three months, or four months, whatever, and then found
that you’re slipping a bit, or your readings are going out
of control again,.
(Patient 10, male, 55–59 years, Kent)
The behavioural impacts indicated by the quotations
above could be attributable to the insights generated by
access to self-monitoring data, however the responses of
some participants also suggested that believing their
readings may be observed by their health providers is
what motivated them to act.
it’s also a deterrent because I like a drink unfortunately
…. It’s sneaky beaky, it’s good sneaky beaky.
(Patient 14, Male, 50–55 years, Lothian)
But knowing that everything’s going to be looked at on a
regular basis by somebody else, it’s actually, it’s not bad
to have a policeman somewhere ….
(Patient 6, male, 50–55 years, Kent)
Practitioners thought the system would be particularly
useful for those using insulin.
I think the patients who this is probably helpful for are
those on the insulin, because they’re the ones who will
be adjusting their insulin dose according to what their
blood sugars are.
(Practice nurse 2).
Supporting treatment changes
The second use of the telemonitoring data was as a basis
to change medical treatment. Frequent testing led to
faster working through treatment protocols in some
cases. However, as shown in the second example, not all
professionals were willing to engage with the home mon-
itoring data.
I’ve got another gentleman that probably he needs to go
on insulin. And we’ve, sort of, been watching whilst we’ve
given him some tablets and they really haven’t made any
difference. So his treatment is going to change quicker
than it would have done, sort of, normally.
(Practice nurse 3)
… from our point of view it’s not really going to change
what we’ll do, I mean I’ll change the medication based
on her next HbA1c result rather than anything else ….
it’s potentially harmful to her to expect that blood
glucose monitoring with home strips is actually useful
when in reality we are just going to be keeping on check-
ing her HbA1c … but I mean who knows whether it’s sti-
mulated her thoughts and feelings about her diabetes
and made her focus more on her diet and things
(GP11)
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Some of these treatment changes were made without
the need for the patient to visit the practice.
I got a letter to say that it [BP] was a wee bit high, and I
was to go and see a doctor, and he said, ‘Well come back
in four weeks’ time,’ but …I didn’t put on an appoint-
ment, because I was going away on holiday … So, by the
time I come back there was a letter there, and they’d
changed my medication.
(Patient 20, male, 55–59 years, Lothian)
The ‘fit’ of telemonitoring with personal lifestyles and
professional practice
Within this theme there were major differences between
patients and professionals. For patients telemonitoring
was not a burden, it was convenient and made sense.
Patients also thought that in the longer term it would
reduce the burden on the practice by reducing the
number of appointments required.
I think that’s beneﬁcial to both the diabetes nurse,
because she can pick up the records from a distance,…
and also it stops me having to physically go so often to
the doctors’ surgery, and I would have thought it would
save a lot of time on the nursing/doctor side.
(Patient 7, male, 50–55 years, Kent)
I thought it was very useful because I was working at that
time and I thought that the doctor was going to know
everything about my illness and I don’t really need to go
and see the doctor.
(Patient 14, male, 50–55 years, Lothian)
However, although some professionals shared the
patients’ view that telemonitoring would be beneﬁcial to
the practice, others were concerned about workload and
cost as shown in these contrasting examples.
I see it having a good impact on the practice, I don’t see
it being a negative impact. I think long term, if the
patients are able to see what their readings are in the
house and keeping an eye on their weight and looking
after their blood pressure……. inevitably they will have
better controlled diabetes ….. The time will free up for
us.
(Practice nurse 1)
I think it’s difﬁcult when you’re constrained by the
pharmaceutical budget, you know, to say to somebody
‘No you can’t have a monitor’ because that’s basically
what we’re being told, you know, the prescribing of the
blood glucose monitoring strips are expensive, and we
shouldn’t routinely be doing this.
(Practice nurse 9)
I mean it’s easy enough to have monitors in various
patients’ houses generating numbers that may or may not
be concerning ….. generating work potentially which we
probably don’t have the capacity to take on.
(GP 11)
The professionals were used to a model of care where
communication with the patient was largely face to face
and many continued with that model even when, from
the patient’s point of view, it was not needed or efﬁcient.
…the receptionist rang up one morning and said, oh,
Doctor [name] wants to see you about your blood test. …
when I got up there, he just said oh yeah, he’d got them
from last week and they were alright, so I don’t know
what the panic… was all about.
(Patient 11, female, 70–74 years, Lothian)
…..this is all good technology but it’s important to review
your patients in person and place everything in context.
(GP 4)
However, as seen above and in this additional
example, some GPs were willing to adjust BP medication
remotely which was very acceptable to patients.
A couple of times they phoned me telling me that my
blood pressure was too high and telling me that they’d
be sending me a new prescription through the post
which they did. I thought that was bloody wonderful.
(Patient 14, male, 50–54 years, Lothian).
DISCUSSION
The ﬁndings from this study suggest that telemonitoring
of blood glucose and BP by people with type 2 diabetes
was feasible. The data generated by telemonitoring sup-
ported self-care decisions and medical treatment deci-
sions. In terms of self-care, the motivation to manage
diet (the preferred method of improving diabetic
control) was not just due to the patient seeing high
blood glucose measurements, but also because the mea-
surements may be seen within the practice, and patients
considered the benign policing aspect of telemonitoring
to be important. A similar ﬁnding was reported in a
recently published study from New Zealand.40 The con-
venience of telemonitoring was very acceptable to
patients although professionals had some concerns
about telemonitoring increasing workload and costs.
The ﬁndings indicated that there was a lack of consensus
on who (patient or practitioner) should initiate commu-
nication if readings were outwith the target range and
the mode of communication, with telephone and letter
being used but some practitioners preferring to see
patients face to face.
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A strength of this study is that it was embedded in an
RCT, (the results of which will be published elsewhere).
Qualitative studies nested within clinical trials of
complex interventions can identify how the intervention
was applied and the mechanism by which it induces
change,41 particularly useful in trials such as this where
guidelines rather than a strict protocol for the use of the
telehealth intervention within the practices were
issued.12 The results can be used to improve future guid-
ance and iterations of the technology. Also professionals
in particular welcomed the chance to test the new tech-
nology with no commitment to continue, and it may
have been used by practices who would not otherwise
have been ‘early adopters’. According to the diffusion of
innovations theory,42 the trialability of an innovation is
one of the properties which affects the chances of it
being adopted, and in the trial context the technology
was easy for practices to try on a small scale.
However, the trial context is also a weakness of the
study, since the lack of full scale commitment to telemo-
nitoring within a practice means that professionals did
not experience providing the service at the scale
required should it be adopted as routine care, and it is
clear that large numbers of successful telehealth pilots
have failed to translate into routine service.8 In addition
participants in RCTs are often not representative of the
wider population of people with diabetes. The participa-
tion rate in the Telescot diabetes trial was only 12% and
there was over representation of men and younger
people and under-representation of more socio-
economically deprived populations compared to the dis-
tributions among people with diabetes in the general
population (S Wild, The impact of supported telemetric
monitoring in people with type 2 diabetes, personal
communication). Also Lothian and Kent have
non-Caucasian ethnic minority populations of only 4%
and 5%, respectively43 44 and, although the ethnic mix
of participants in the trial and this qualitative study was
representative of the local populations, this study could
not provide insight into the acceptability of telemonitor-
ing for these groups who are at higher risk of type 2
diabetes.
The results of the Telescot programme of qualitative
studies of telemonitoring27–33 show a number of
common themes. Where this study differed is in the
strong self-management response. Type 2 diabetes is the
only condition which patients said that they expected to
self-manage on a day-to-day basis even though over the
long term it was difﬁcult to maintain motivation. As well
as supporting self-care, the telemonitoring data sup-
ported optimisation of treatment, particularly in relation
to BP. Patients found telemonitoring a convenient way to
communicate with healthcare professionals. However,
some professional responses were more wary and suggest
a lack of ‘ﬁt’ between telemonitoring and current expec-
tations of professional practice which may limit transla-
tion into routine practice.45 Other studies have
suggested that much more attention needs to be paid to
workﬂow within practices when designing telehealth
systems which will be acceptable on a long-term
basis.33 46 Despite this, there was evidence that some pro-
fessionals were willing to change BP medication without
seeing the patient face to face, although for others that
remained the only mode of communication.
CONCLUSIONS
Telemonitoring in type 2 diabetes was well accepted by
trial participants and increased motivation to improve
self-management. It also provided clinicians with a quan-
titative basis on which to improve the medical manage-
ment of BP. Some professionals harboured concerns
about the potential for the service to increase workload
and cost and some expressed a reluctance to move away
from traditional exclusive face to face care, but this was
not universal. There is need for further reﬁnement of
telehealthcare delivery models and technical improve-
ments in telemonitoring systems, as well as wider cultural
change on the part of patients and clinicians. More evi-
dence of the beneﬁcial effects of these interventions on
patients’ self-care motivation and behaviour may help to
encourage clinicians to adopt these technologies in
routine practice.
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